Iqbal Aslam, Alarayedh Mohamed, Iqbal Tahir, Olugbuyi Samuel, Hicks-Walsh Claire
Psychiatry, Lincolnshire Partnership National Health Service (NHS) Foundation Trust, Lincoln, GBR.
Cureus. 2025 Aug 13;17(8):e89967. doi: 10.7759/cureus.89967. eCollection 2025 Aug.
Lewy body dementia (LBD) is a progressive neurodegenerative disorder presenting with a wide range of cognitive, sleep, neuropsychiatric, motor, and autonomic symptoms. Diagnosing LBD in individuals with established psychiatric conditions, particularly chronic schizophrenia, presents significant challenges due to overlapping clinical features. This case report outlines a case of a 78-year-old woman with a 48-year history of paranoid schizophrenia, who on her last admission exhibited new behavioural and functional decline. This included increased agitation, incoherent mumbling, visual hallucinations, self-harming behaviour, motor symptoms, and reduced responsiveness. Over time, she became increasingly frail and was displaying signs of extrapyramidal side effects on therapeutic doses of haloperidol. Her presentation triggered regular comprehensive multidisciplinary team (MDT) discussions and reassessments, especially when the medical staff noted worsening motor symptoms, hypersensitivity to antipsychotics, and cognitive fluctuations. Although her primary psychiatric diagnosis had been schizophrenia for nearly five decades, the clinical evolution strongly indicated LBD, an emerging neurodegenerative process. Despite the absence of radiologic evidence, largely due to her condition, her new symptoms aligned with the diagnostic criteria for LBD. Subsequently, due to her poor physiological reserve, she was managed under a palliative care pathway. This case highlights the importance of periodic diagnostic reassessment in a patient with a long-standing psychiatric disorder. Without careful review, there is a risk of diagnostic overshadowing, where new symptoms observed are miscredited to a historical diagnosis. Additionally, anchoring bias can further add to the issue as clinicians become fixated on the initial diagnosis. As a result, differentiating between chronic psychosis and evolving neurodegenerative conditions like LBD is crucial to avoid inaccurate management and to develop appropriate care plans, especially in vulnerable patients.
路易体痴呆(LBD)是一种进行性神经退行性疾病,表现出广泛的认知、睡眠、神经精神、运动和自主神经症状。在患有既定精神疾病,尤其是慢性精神分裂症的个体中诊断LBD,由于临床特征重叠而面临重大挑战。本病例报告概述了一名患有偏执型精神分裂症48年的78岁女性病例,她在最后一次入院时出现了新的行为和功能衰退。这包括躁动增加、言语不清、视幻觉、自伤行为、运动症状和反应性降低。随着时间的推移,她变得越来越虚弱,并且在服用治疗剂量的氟哌啶醇时出现了锥体外系副作用的迹象。她的病情引发了定期的全面多学科团队(MDT)讨论和重新评估,尤其是当医务人员注意到运动症状恶化、对抗精神病药物过敏以及认知波动时。尽管她的主要精神科诊断为精神分裂症已近五十年,但临床进展强烈提示为LBD,这是一种新出现的神经退行性过程。尽管缺乏放射学证据,主要是由于她的病情所致,但她的新症状符合LBD的诊断标准。随后,由于她的生理储备较差,她在姑息治疗路径下接受管理。本病例强调了对患有长期精神疾病的患者进行定期诊断重新评估的重要性。如果不仔细审查,存在诊断遮蔽的风险,即观察到的新症状被错误地归因于既往诊断。此外,锚定偏差可能会进一步加剧这个问题,因为临床医生会执着于初始诊断。因此,区分慢性精神病和像LBD这样不断演变的神经退行性疾病对于避免不准确的管理和制定适当的护理计划至关重要,尤其是在脆弱患者中。